Multiple Manufacturers

ERYTHROCIN LACTOBIONATE

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Multiple Manufacturers

Erythrocin Lactobionate HCPCS:

J1364

HCPCS Code Descriptor:

Injection, erythromycin lactobionate, per 500 mg

Category:

J Code

Erythrocin Lactobionate NDCs:

00409-6476-44, 14789-0116-05, 00409-6482-01

Primary Type:

Antibiotic

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Erythrocin Lactobionate CPT Codes:

Potential CPT administration codes for Erythrocin Lactobionate can be found at the following link.

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00409-6476-44, 14789-0116-05, 00409-6482-01

About Erythrocin Lactobionate:

ERYTHROCIN LACTOBIONATE is a medication manufactured by multiple manufacturers and aligned to the J Code: J1364. ERYTHROCIN LACTOBIONATE is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1364 Added Date:

January 1, 1995

J1364 Effective Date:

January 1, 2023

J1364 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Erythrocin Lactobionate billing and coding information.
Our team did not identify a source for Erythrocin Lactobionate patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for ERYTHROCIN LACTOBIONATE
Our team has not yet identified a source of side effects information for ERYTHROCIN LACTOBIONATE. Please check back in a few weeks.